24小时热门版块排行榜    

查看: 264  |  回复: 2
【奖励】 本帖被评价2次,作者msd2phd增加金币 1.5 个
当前主题已经存档。

msd2phd

至尊木虫 (职业作家)


[资源] Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug

Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug

Publisher: Wiley-VCH
Number Of Pages: 576
Publication Date: 1999-06-10

30 years after its discovery as an antitumor agent, cisplatin represents today one of the most successful drugs in chemotherapy. This book is intended to reminisce this event, to take inventory, and to point out new lines of development in this field. Divided in 6 sections and 22 chapters, the book provides an up-to-date account on topics such as

the chemistry and biochemistry of cisplatin,
the clinical status of Pt anticancer drugs,
the impact of cisplatin on inorganic and coordination chemistry,
new developments in drug design, testing and delivery.
It also includes a chapter describing the historical development of the discovery of cisplatin. The ultimate question - How does cisplatin kill a cell? - is yet to be answered, but there are now new links suggesting how Pt binding to DNA may trigger a cascade of cellular reactions that eventually result in apoptosis. p53 and a series of damage recognition proteins of the HMG-domain family appear to be involved. The book addresses the problem of mutagenicity of Pt drugs and raises the question of the possible relevance of the minor DNA adducts, e.g. of interstrand cross-links, and the possible use of trans-(NH3)2Pt(II)-modified oligonucleotides in antisense and antigene strategies. Our present understanding of reactions of cisplatin with DNA is based upon numerous model studies (from isolated model nucleobases to short DNA fragments) and application of a large body of spectroscopic and other physico-chemical techniques. Thanks to these efforts there is presently no other metal ion whose reactions with nucleic acids are better understood than Pt. In a series of chapters, basic studies on the interactions of Pt electrophiles with nucleobases, oligonucleotides, DNA, amino acids, peptides and proteins are reported, which use, among others, sophisticated NMR techniques or X-ray crystallography, to get remarkable understanding of details on such reactions. Reactivity of cisplatin, once bound to DNA and formerly believed to be inert enough to stay, is an emerging phenomenon. It has (not yet) widely been studied but is potentially extremely important. Medicinal bioinorganic chemistry - the role of metal compounds in medicine - has received an enormous boost from cisplatin, and so has bioinorganic chemistry as a whole. There is hardly a better example than cisplatin to demonstrate what bioinorganic chemistry is all about: The marriage between classic inorganic (coordination) chemistry and the other life sciences - medicine, pharmacy, biology, biochemistry. Cisplatin has left its mark also on areas that are generally considered largely inorganic. The subject of mixed-valance Pt compounds is an example: From the sleeping beauty it made its way to the headlines of scientific journals, thanks to a class of novel Pt antitumor agents, the so-called "platinum pyrimidine blues". In the aftermath diplatinum (III) compounds were recognized and studies in large numbers, and now an organometalic chemistry of these diplatinum (III) species is beginning to emerge. The final section of the book is concerned with new developments such as novel di- and trinuclear Pt(II) drugs with DNA binding properties different from those of cisplatin, with orally active Pt(IV) drugs which are presently in clinical studies, and with attempts to modify combinatorial chemistry in such a way that it may become applicable to fast screening of Pt antitumor drugs. The potential of including computational methods in solving questions of Pt-DNA interactions is critically dealt with in the concluding chapter.


http://mihd.net/mw8tza
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

yinjj

金虫 (职业作家)


★★★★★ 五星级,优秀推荐

2楼2007-11-05 08:37:57
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 msd2phd 的主题更新
☆ 无星级 ★ 一星级 ★★★ 三星级 ★★★★★ 五星级
普通表情 龙 兔 虎 猫 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[公派出国] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +3 zSbvVX9JFl9J 2026-11-09 3/150 2026-11-10 01:40 by FChKX8meu1ds
[考博] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +3 zSbvVX9JFl9J 2026-11-09 4/200 2026-11-10 01:29 by FChKX8meu1ds
[考博] 27博士申请 +3 白白白ly 2026-11-09 3/150 2026-11-09 21:39 by szq0819
[文学芳草园] 厉娜 +3 张丹枫1991 2026-11-09 5/250 2026-11-09 16:53 by 张丹枫1991
[考博] 售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急 +5 kvewwGtKktqB 2026-11-04 12/600 2026-11-09 13:26 by Equinoxhua
[考研] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +5 ttH3f1oA6ace 2026-11-04 15/750 2026-11-09 13:19 by Equinoxhua
[考研] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +6 5sJFDKp2kwuI 2026-11-06 14/700 2026-11-09 11:52 by GwrQVVR6Oenx
[考博] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +5 5sJFDKp2kwuI 2026-11-06 15/750 2026-11-09 11:41 by GwrQVVR6Oenx
[硕博家园] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +4 5sJFDKp2kwuI 2026-11-06 10/500 2026-11-09 08:00 by IhnEQauGmT3K
[考研] 售SCI一区T0P文章,我:8O.55.1.O.54,科目全,可伽急 +3 5sJFDKp2kwuI 2026-11-06 12/600 2026-11-09 06:32 by l48hFd8Nwae2
[教师之家] 售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急 +4 5sJFDKp2kwuI 2026-11-06 8/400 2026-11-08 23:01 by l48hFd8Nwae2
[教师之家] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +5 5sJFDKp2kwuI 2026-11-06 9/450 2026-11-08 22:46 by l48hFd8Nwae2
[教师之家] 延安大学回应“副教授留绝笔信”:确已离世,正核实举报内容 +3 yexuqing 2026-11-04 5/250 2026-11-07 13:22 by 苏东坡二世
[公派出国] 售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急 +5 ttH3f1oA6ace 2026-11-04 10/500 2026-11-06 16:12 by 5sJFDKp2kwuI
[公派出国] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +6 ttH3f1oA6ace 2026-11-04 12/600 2026-11-06 16:10 by 5sJFDKp2kwuI
[硕博家园] 售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急 +6 kvewwGtKktqB 2026-11-04 16/800 2026-11-06 05:00 by qL1cU46YIdK0
[考博] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +4 ttH3f1oA6ace 2026-11-04 7/350 2026-11-06 02:13 by qL1cU46YIdK0
[考研] 售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急 +4 ttH3f1oA6ace 2026-11-04 10/500 2026-11-06 02:04 by qL1cU46YIdK0
[硕博家园] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +3 ttH3f1oA6ace 2026-11-04 9/450 2026-11-06 02:02 by qL1cU46YIdK0
[硕博家园] 售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急 +4 hNpp4Y2CGvSC 2026-11-04 12/600 2026-11-06 01:53 by qL1cU46YIdK0
信息提示
请填处理意见